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Cultured primary human keratinocytes are frequently employed for studies of immunological and inﬂammatory responses;
however, interpretation of experimental data may be complicated by donor to donor variability, the relatively short culture
lifetime, and variations between passages. To standardize the in vitro studies on keratinocytes, we investigated the use of HaCaT
cells, a long-lived, spontaneously immortalized human keratinocyte line which is able to diﬀerentiate in vitro, as a suitable
model to follow the release of inﬂammatory and repair mediators in response to TNFα or IL-1β. Diﬀerent treatment conditions
(presence or absence of serum) and diﬀerentiation stimuli (increase in cell density as a function of time in culture and elevation
of extracellular calcium) were considered. ELISA and Multiplex measurement technologies were used to monitor the production
of cytokines and chemokines. Taken together, the results highlight that Ca2+ concentration in the medium, cell density, and
presence of serum inﬂuences at diﬀerent levels the release of proinﬂammatory mediators by HaCaT cells. Moreover, HaCaT
cells maintained in low Ca2+ medium and 80% conﬂuent are similar to normal keratinocytes in terms of cytokine production
suggesting that HaCaT cells may be a useful model to investigate anti-inﬂammatory interventions/therapies on skin diseases.
1. Introduction
The skin is a continuously self-renewing organ that dynami-
cally manages the outside-inside-outside relationships of the
human body and actively participates in the host defenses
[1]. Keratinocytes (KCs) represent 95% of the epidermal
cells. Primarily, they play the structural and barrier function
of the epidermis, but their role in the initiation and
perpetuation of skin inﬂammatory and immunological
responses, and wound repair, is also well recognized [2].
Under homeostatic conditions, KCs diﬀerentiate and
mature from proliferating nucleated basal cells to the highly
diﬀerentiated, nucleus-free corneocytes. Each stage of diﬀer-
entiation is characterized by the expression of structural
proteins, such as keratins (K) and lipids [3, 4]. For example,
the expression of K5 and K14 is restricted to the basal layer,
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whereas K1 and K10 appear on more diﬀerentiated supraba-
sal cells [4], and involucrin, loricrin, and keratolinin, in the
cells of the uppermost spinous layer [1]. Terminal diﬀerenti-
ation is driven by various cytokines and growth factors, and it
is typically associated with the formation of the peripheral
envelopes, rich in proteins and lipids [3, 4]. The calcium
(Ca2+) gradient in the epidermis, increasing from the basal
to the granular layer, represents one of the most important
triggers of KC diﬀerentiation [4].
Resting KCs produce epidermal growth factor receptor
(EGFR) ligands and vascular endothelial growth factor
(VEGF), but when activated by bacterial products or by
direct damage by UV light or chemicals, the expression of
cytokines and chemokines changes [5, 6]. In skin diseases,
such as psoriasis [7] or atopic dermatitis [8], the cytokine/
chemokine network is even more complex and autocrine/
paracrine loops are described [2].
Cultured human KCs are frequently employed for
studies of KC functions in chronic inﬂammatory skin
diseases [9, 10]. Primary KCs cultured in vitro at low Ca2+
concentration retain a basal phenotype, and they diﬀerentiate
upon addition of Ca2+> 0.1mM [11, 12]. However, their use
for routine monitoring of the inﬂammatory response of the
inﬂamed skin presents major drawbacks. Firstly, fresh
human KCs require supplementary growth factors to survive
and proliferate in vitro; secondly, once induced to diﬀerenti-
ate, they rapidly die and do not allow long-term investigation
of the diﬀerentiation signals [13]. Moreover, donor-to-donor
variability in growth characteristics and in vitro responses,
diﬀerent plating eﬃciencies, the short lifetime in culture,
and the changes in proliferation and diﬀerentiation charac-
teristics with increasing number of passages, complicates
the interpretation of experimental data.
To minimize these problems, the spontaneously immor-
talized human KC cell line HaCaT from adult skin has been
proposed as a model for the study of KC functions. HaCaT
is a nontumorigenic monoclonal cell line, adapted to long-
term growth without feed-layer or supplemented growth
factors [13, 14]; it exhibits normal morphogenesis and
expresses all the major surface markers and functional activ-
ities of isolated KC [14]; upon stimulation, HaCaT cells
diﬀerentiate and express speciﬁc markers of diﬀerentiation,
such as K14, K10, and involucrin. They can also form strati-
ﬁed epidermal structure [15], but they can revert, back and
forth, between a diﬀerentiated and a basal state upon changes
in Ca2+ concentration in the medium [16]; they retain the
capacity to reconstitute a well-structured epidermis after
transplantation in vivo [17].
The aim of the present study was to investigate and
optimize the best conditions to use HaCaT cells as a reli-
able in vitro model to evaluate, at diﬀerent stages of diﬀer-
entiation, the production of proinﬂammatory mediators,
chosen among those mostly involved in skin inﬂammation
and angiogenesis.
2. Materials and Methods
2.1. Cell Culture. HaCaT cells, spontaneously immortalized
human keratinocyte line [15], were kindly provided by Cell
Line Service GmbH (Eppelheim, Germany) and cultured in
5% CO2 at 37
°C in regular Dulbecco’s Modiﬁed Eagle’s
Medium (DMEM) (Euroclone S.P.A., Milan, Italy) contain-
ing 1.8mM Ca2+, or with DMEM (Gibco, Life Technologies,
Carlsbad, CA, USA) at low concentration of Ca2+ (0.07mM).
Both media were supplemented with 10% heat-inactivated
fetal bovine serum, glutamine (2mM), penicillin (100U⁄ml)
(Euroclone), and streptomycin (100mg⁄ml) (Euroclone).
For all experiments, cells were seeded at a density of
5.7× 103 cells⁄cm2 and cultured with DMEM at high or low
Ca2+concentration for 6 or 14 days. The samples were labeled
as follows: A6, cells cultured for 6 days with low Ca2+ concen-
tration (0.07mM) and tested when 80% conﬂuent; A14, cells
cultured for 14 days with low Ca2+ concentration (0.07mM)
and tested when overconﬂuent; C6, cells cultured for 6 days
with high Ca2+ concentration (1.8mM) and tested when
80% conﬂuent; and C14, cells cultured for 14 days with high
Ca2+ concentration (1.8mM) and tested when overconﬂuent.
The medium was changed every 2 days. A ﬂow chart with
details of the experimental protocol is reported in Figure 1.
2.2. Isolation of Human Keratinocytes from Skin Biopsies. Pri-
mary KCs were isolated from nonlesional skin biopsies
obtained from adult psoriatic patients not receiving either
topical or systemic therapies for at least 6 months, or at the
time of sample collection. To separate the epidermal layer
from the basement membrane, the 0.4mm punch biopsy
was treated with dispase (Gibco BRL, Gaithersburg, MD,
USA). After 18 h at 4°C, the epidermal sheet was separated
mechanically and dissociated with TrypLE (Gibco BRL,
Gaithersburg, MD, USA) for 20min at 37°C. The obtained
primary cells were then plated on 6-well tissue culture plates
(Costar), precoated with coating matrix (type I collagen,
Gibco BRL), cultured using a speciﬁc keratinocyte-serum-
free media at low Ca2+ concentration (<0.07mM), and
supplemented with human keratinocyte growth factors
(Gibco BRL). When the monolayer reached 60%–70%
conﬂuence, cells were split by trypsinization. For all the
experiments, keratinocyte cultures between the third and
fourth passages were used. Informed consent was obtained
from all donors providing tissue samples, and ethical
approval was obtained from the Ethics Committee of “La
Sapienza” University, Rome, Italy.
2.3. Cell Proliferation Assay. The proliferation of HaCaT cells
was determined at the indicated intervals using the MTT col-
orimetric assay as described [18]. This test is based on the
ability of succinic dehydrogenase of living cells to reduce
the yellow salt MTT (3-(4,5-dimethylthiazol-2-yl-2,5-diphe-
nyltetrazolium bromide)) (Sigma-Aldrich, St. Louis, MO,
USA) to a purple-blue insoluble formazan precipitate. Exper-
iments were performed in 96-well plates containing a ﬁnal
volume of 100 μl of medium/well. Cells were seeded at an ini-
tial density of 1.0× 104 cells/cm2, and, after 1, 6, 9, and 14
days, incubation medium was removed and replaced by
100 μl of fresh medium. Then, 10 μl of stock MTT solution
(5mg/ml in PBS) was added and plates were incubated at
37°C for 4 h. Finally, 100 μl of 10% sodium dodecyl sulfate
(SDS) (Sigma-Aldrich, St. Louis, MO, USA), in 0.01M HCl,
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was added to each well and the amount of formazan formed
was measured at 540nm using a Benchmark microplate
reader (Bio-Rad, Richmond, CA, USA). Sixteen wells per
time-point were analyzed in three independent experiments.
2.4. Cell Stimulation. For the stimulation of HaCaT cells, an
amount of 1.0× 104 cells/well in 500 μl were seeded in
24-well plate and cultured in low or high Ca2+ medium, with
medium changes every two days. After 6 or 14 days, the
medium was removed and replaced with 250μL of medium
or serum-free medium, supplemented with TNFα (10 ng/ml)
or IL-1β (10 ng/ml) (PeproTech EC, Ltd., London, UK).
After diﬀerent lengths of time (6, 24, or 48 hours) at 37°C,
the supernatants from two wells for each diﬀerent treatment
and time were pooled in a single tube and frozen at −20°C to
be subsequently analyzed for the presence of cytokines, che-
mokines, and growth factors. The cell monolayers were then
washed twice with PBS, Ca2+, and magnesium-free medium,
dried, and stored at −20°C for the analysis of DNA content.
For the stimulation of keratinocytes from skin biopsies,
8–10× 104 cells/cm2 in 3ml were seeded in 6-well plate and
cultured in low Ca2+ medium, with medium changes every
two days. When the cells reached 60%–70% conﬂuence,
the medium was removed and replaced with 3ml of
serum-free medium, supplemented with TNFα (10 ng/ml).
After 48 hours of incubation at 37°C, the supernatant was
collected, frozen at −80°C, and subsequently analyzed for
the presence of cytokines, chemokines, and growth factor as
described in the multiplex system section.
2.5. Release of Inﬂammatory Mediators
2.5.1. ELISA. The release of CXCL8/IL8 and VEGF from
HaCaT cells was quantiﬁed by using two diﬀerent high sensi-
tivity human ELISA set (Peprotech, Rocky Hill, NJ, USA)
following the method described below. Brieﬂy, Corning 96-
well EIA/RIA plates from Sigma-Aldrich (Milan, Italy) were
coated with the antibodies provided, overnight at 4°C. Matrix
metalloproteinase-9 (MMP-9) secretion from HaCaT cells
was evaluated by a diﬀerent ELISA set (RayBio® Human
MMP-9 ELISA kit, Norcross, GA) using a precoated
96-well plate, supplied with the kit. In all the three cases,
300μl of samples was transferred in duplicate into wells at
room temperature for 2 hours. The results were detected by
spectroscopy (signal read 450nm, 0.1 s, by VictorTM X3)
using biotinylated and streptavidin-HRP conjugate antibod-
ies, evaluating 3,5,3,59-tetramethylbenzidine (TMB) sub-
strate reaction. The quantiﬁcation of analytes was done
using an optimized standard curve supplied with the ELISA
sets. The data are expressed as pg/106 cells. Results are
mean± SD of at least three independent cell culture experi-
ments in duplicate.
2.5.2. Bioplex Multiplex System. Supernatants obtained from
HaCaT cells and from primary keratinocytes, stimulated or
not with TNFα (10 ng/ml) for 48 hours, were analyzed for the
presence of chemokines, cytokines, and growth factors.
Regarding chemokines, we assayed CXC chemokine ligands
(CXCL1/GRO,CXCL10/IP10,CXCL12/SDF-1, andCX3CL1/
fractalkine) and CC chemokine ligands (CCL2/MCP1, CCL3/
MIP1a, CCL4/MIP1b, CCL5/RANTES, CCL7/MCP3, CCL1
1/eotaxin, and CCL22/MDC). Among cytokines, we assayed
TGFα, TNFβ, IFN-α2, IFN-γ, G-CSF, GM-CSF, IL-10, IL-
12p70, IL-15, and IL-33. All factors were quantiﬁed simulta-
neously by Bio-Plex Pro human cytokine assays according to
the manufacturer’s instructions (Bio-Plex Bio-Rad Labora-
tories, CA, USA). The analyte levels were determined using
Bio-Plex array reader (Luminex, Austin, TX, USA) and the
Bio-Plex manager software. The relative concentration of
each analyte was obtained through the establishment of stan-
dard curves, and results are expressed as pg/106 cells.
2.6. Analysis of DNA Content. Analysis of DNA content was
performed using the commercial kit ﬂuorimetric “FluoRe-
porter Blue Fluorometric DNA Quantitation Kit” (Molecular
Probes, Life Technologies, Carlsbad, CA, USA) in 96-well
(i)
(ii)
(iii)
(iv)
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DNA and protein content
Western blot 
Immunouorescence
HaCaT
6 days
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> 100%
conuence
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Figure 1: A ﬂow chart with details of the experimental protocol performed on HaCaT cells.
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plates following the manufacturer’s instructions. Plates with
treated HaCaT cells were thawed, and 200 μL of distilled
H2O was added to each well. After three cycles of freezing-
thawing, 100 μl was then transferred into a 96-well
plate and used for the assay. In parallel, the standard
calibration curve was made using increasing concentrations
(0–1000 ng/100 μl) of DNA from calf thymus diluted in TE
buﬀer (10 mM Tris base, 1mM EDTA in distilled H2O entire
solution with a pH equal to 7.4). The amount of 100 μL of
Hoechst dye was then added to each well containing the
sample or standard, previously diluted 1 : 400 in TNE buﬀer
(10 mM Tris, 2M NaCl, 1mM EDTA with a ﬁnal pH of
7.4, and 2mM sodium azide). The emitted ﬂuorescence was
measured with microplate reader TECAN F500 (Tecan,
Maennedorf, Switzerland) using excitation and emission
wavelengths at 346 nm and 460nm, respectively. The DNA
content was calculated by interpolation of the absorbance
of the samples on the calibration curve. The DNA content
was expressed as μg DNA/106 cells counted, in each well,
using a Burker chamber and trypan blue.
2.7. Protein Extraction and Analysis of Protein Content. For
total protein extraction, HaCaT cells were cultured for 6 or
14 days with proper medium. For each time-point of the
diﬀerentiation, cells were washed with cold PBS and lysed
in RIPA lysis buﬀer (0.5% deoxycholate, 1% Nonidet P-40,
0.1% SDS, 100μg/ml of phenylmethylsulfonyl ﬂuoride
(PMSF), 1mM Na2VO4, and 8.5μg⁄ml of aprotinin, in
PBS), shaking for 20min at 4°C. Samples were collected by
scraper, incubated for 60min at 4°C, and centrifuged at
12.000 rpm for 15min at 4°C, and the supernatant was col-
lected and frozen at −20°C until use. The soluble proteins
in the extract were quantiﬁed according to the method
described by Lowry et al. [19].
2.8. Western Blot Analysis. For Western blot analysis, 40 μl of
total protein was separated on 7.5% SDS-PAGE gel and
transferred to a polyvinylidenediﬂuoride transfer membrane
(PVDF) (Bio-Rad, Richmond, CA, USA) for 16 h at 150mA,
using transfer buﬀer (25mM TrisHCl, 190mM glycine, 20%
methanol, and 0.05% SDS). The membranes were blocked by
incubation in blocking buﬀer (PBS containing 0.1% Tween
and 5% dried nonfat milk) for 2 h and 30min at room
temperature. Then, membranes were blotted overnight at
4°C with various dilutions of primary antibodies, speciﬁcally,
rabbit polyclonal IgG anti-involucrin (1 : 2500; Genetex,
Irvine, CA, USA), mouse polyclonal IgG anti-cytokeratin 14
(1 : 1500; Santa Cruz Biotechnology Inc., Santa Cruz, CA,
USA), and rabbit monoclonal IgG anti-cytokeratin 10
(1 : 10,000; Genetex, Irvine, CA USA). Mouse monoclonal
anti-β-actin antibody (1 : 6000; Sigma-Aldrich, St. Louis,
MO, USA) was used to normalize gel loading. Blots were
washed six times with PBS-0.1% Tween and incubated for
1 h at room temperature with horseradish peroxidase-
linked secondary antibodies. Involucrin and K10 were
detected with a donkey anti-rabbit IgG (1 : 10,000; Santa Cruz
Biotechnology Inc., Santa Cruz, CA, USA). For K14 and
actin, a goat anti-mouse IgG (1 : 10,000; Santa Cruz Biotech-
nology Inc., Santa Cruz, CA, USA) was used. All blots were
developed by ECL Western blotting detection LiteAblot®
plus Kit Reagent (Euroclone S.P.A., Milan, Italy), following
the manufacturer’s protocol. Immunoreactive proteins
were visualized by autoradiography on Hyperﬁlm ECL
(GE Healthcare Life Sciences, UK). The relative intensities
of band signals were quantiﬁed by digital scanning densi-
tometry, and β-actin was used to normalize the results
to protein content.
2.9. Immunoﬂuorescence. HaCaT and primary keratinocytes,
cultured on 8-well slide chambers, were washed with PBS,
ﬁxed, and permeabilized in ice-cold methanol for 5min.
First, cells were incubated in PBS containing 0.1% bovine
serum albumin (BSA) for 10min, then were incubated with
primary antibodies against K10 (rabbit monoclonal IgG
anti-cytokeratin 10; 1 : 200; Genetex, Irvine, CA, USA) for
60min in PBS containing 1% BSA. The cells were subse-
quently incubated with secondary antibody Alexa Fluor®
488-labeled goat anti-rabbit IgG and Alexa Fluor 488-
labeled goat anti-mouse IgG (1 : 1000, Invitrogen, Life Tech-
nologies, Carlsbad, CA, USA) for 30min, respectively. The
nuclei of the cells were stained with 4′,6-diamidino-2-pheny-
lindole (DAPI; Sigma-Aldrich, St. Louis, MO, USA), which
speciﬁcally recognizes DNA. The slides were observed by
using Nikon Eclipse TE200 inverted microscope with immer-
sion objective at 60x magniﬁcation and photographed with
Nikon digital camera (Nikon, Japan).
2.10. Statistical Analysis. Data are expressed as mean± SD of
at least three experiments performed in duplicate. Data were
analysed by unpaired one-way analysis of variance
(ANOVA) followed by Bonferroni post hoc test. Statistical
analysis was done using GraphPad Prism 5.0 software
(GraphPad Software Inc., San Diego, CA, USA). p < 0 05
was considered statistically signiﬁcant.
3. Results
3.1. Eﬀect of Extracellular Ca2+ and Cell Density on
Proliferation and Diﬀerentiation of HaCaT Cells. To set up
and validate HaCaT cells as an in vitro model to study the
inﬂammatory response of human keratinocytes, two known
stimuli of KC diﬀerentiation, cell density and extracellular
Ca2+ concentration, were used. HaCaT cells were plated at
the same density in low (0.07mM) and high (1.8mM) Ca2+
medium, and cell proliferation was assessed by both MTT
assay and cell counts at day 6 and day 14.
In low Ca2+ medium, a steady increase in metabolic activ-
ity and cell numberwas observed over time, while in highCa2+
medium, cell growth was slower. Comparing low to high Ca2+
medium, about 27.5%and70.3%decrease ofMTTactivity and
40% and 60%decrease in cell count were seen at days 6 and 14,
respectively (Figure 2(a) and Table 1S). However, no signiﬁ-
cant changes in cellmorphologywere observed in the diﬀerent
conditions. Phase contrast images showed that HaCaT cells
were ﬂat and spread out after 6 days of growth both in low
(A6) or high (C6) Ca2+ medium when they were at 80%
conﬂuence; at day 14 both in low (A14) and high (C14) Ca2+
concentration, they becamemore cubical in shapewith higher
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Figure 2: Proliferation and diﬀerentiation of HaCaT cells in low (0.07mM) and high (1.8mM) Ca2+-containing medium. (a) Proliferation of
HaCaT cells plated at the same density (1.0× 104 cells/cm2) assessed by the MTT assay at 2, 6, 9, and 14 days of incubation. Values represent
mean± SD of three independent experiments. (b) Western blot analysis of the expression of keratinocyte (KC) diﬀerentiation markers (K10,
K14, and involucrin) in HaCaT cells grown in low (a) and high (c) Ca2+-containing medium for 6 (A6 and C6) or 14 (A14 and C14) days. The
relative intensities of band signals quantiﬁed by digital scanning densitometry are reported in the histogram; β-actin was used to normalize
the results to protein content. This blot is a representative of three independent experiments. (c) Immunoﬂuorescence staining of HaCaT cells,
grown in low (A) and high (C) Ca2+-containing medium for 6 (A6 and C6) and 14 (A14 and C14) days, and of primary human KC, grown in
low Ca2+-containing medium, with anti-K10 antibodies (magniﬁcation: 60x).
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cell-to-cell packing and stratiﬁcation (Figure S1). As reported
in Table 1S, no signiﬁcant changes were observed in the DNA
and protein content in HaCaT cells grown in medium with
diﬀerent Ca2+ concentrations at the 6th or 14th day.
The expression of three classical KC diﬀerentiation
markers (K14, K10, and involucrin) in response to changes
in cell density and extracellular Ca2+ levels was assessed by
Western blot analysis. Physiologically, the expression of
K14 is restricted to the epidermal basal layer, while the
presence of K10 and involucrin indicates a more diﬀerenti-
ated phenotype.
As shown in Figure 2(b), the expression of K14 was
higher in HaCaT cells at 80% conﬂuence (day 6) than in
overconﬂuent cells (day 14). At the same time, the levels
of K10 and involucrin increased from day 6 to day 14,
conﬁrming the role of cell density on diﬀerentiation. Com-
paring day 6 to day 14, the fold increase in low Ca2+ medium
was more evident for involucrin than for K10 (10.4-fold ver-
sus 5.7-fold, resp.), whereas in high Ca2+ medium, the
increase was 4.7-fold versus 3.2-fold, respectively.
Regarding the eﬀect of Ca2+, at day 6, HaCaT cells
showed similar levels of K14, K10, or involucrin in A6 and
C6 culture conditions, suggesting that Ca2+ concentration
did not signiﬁcantly inﬂuence their expression at 80% cell
conﬂuence (Figure 2(b)). Unexpectedly, at day 14, the levels
of both K10 and involucrin were slightly lower in overconﬂu-
ent HaCaT cells grown in high compared to low Ca2+
medium (Figure 2(b)). This result could be a consequence
of their lower density (Table 1S).
The acquisition of HaCat cell-diﬀerentiated phenotype
was conﬁrmed by immunoﬂuorescence experiments
(Figure 2(c)). The expression of the diﬀerentiation marker
K10 increased signiﬁcantly in HaCaT cells at day 14
compared to day 6 with almost 100% cells being positive. In
addition, again, no diﬀerences in K10 levels were seen
between HaCaT cells grown in low or high Ca2+ medium
both in 80% conﬂuent or overconﬂuent cells. Control sam-
ples without primary antibodies were negative, conﬁrming
speciﬁcity (data not shown).
The pattern of K10 expression was also evaluated on
primary human keratinocytes grown in low Ca2+ and
serum-free medium. Interestingly, as shown in Figure 2(c),
K10 expression on human primary keratinocytes paralleled
HaCaT cells grown for 6 days in low Ca2+ medium (A6).
3.2. Release of Inﬂammatory Mediators from HaCaT Cells.
HaCaT cells grown in diﬀerent culture conditions described
above were then utilized to evaluate the production of a series
of bioactive molecules, known to be released in the skin dur-
ing inﬂammation or repair, both in basal conditions and
upon proinﬂammatory stimulation.
In a ﬁrst set of experiments, we focused on three main
mediators: CXCL8/IL8, VEGF, andMMP-9, which are crucial
for inﬂammatory cell recruitment, angiogenesis, and matrix
remodeling, respectively. TNFα and IL-1β were used as
stimuli. Inﬂuence of serum in the medium was also veriﬁed.
The supernatants were obtained from HaCaT cells plated
at the same density in low or high Ca2+ medium and treated,
after 6 or 14 days of culture, with 10 ng/ml TNFα or IL-1β for
6 or 24h, as indicated, in absence (Figure 2(a)) or presence of
serum (Figure 2(b)). The supernatants were recovered to
measure CXCL8/IL8, VEGF, and MMP-9 by ELISA tests.
The results are reported in Figure 3 and Figure S2.
Compared to basal levels, the stimulation with TNFα in
the absence of serum induced a signiﬁcant increase of
CXCL8/IL8 and MMP-9, but not of VEGF, both in low and
high Ca2+ medium at day 6 (Figure 3(a)). Conversely, the
presence of serum during TNFα treatment at day 6 that
did not elicit appreciable eﬀects on CXCL8/IL8 release
lowered the TNFα-induced MMP-9 release and increased
both basal and stimulated levels of VEGF (Figure 3(b)).
The concentration fold increase, following TNFα stimulation,
was serum independent.
Overall, it appears that the ability of HaCaT cells of
releasing these mediators decreased appreciably at day 14,
compared to day 6, and this is independent on the Ca2+ con-
centration or the presence of serum (Figure 3). Of note, the
MMP-9 amount released at day 6 and day 14 is higher in
the absence than in the presence of serum, both in basal con-
dition and upon stimulation.
Similar proﬁles were observed when cells were stimulated
with IL-1β (10 ng/ml) (Figure S2). Higher levels of CXCL8/
IL8, VEGF, and MMP-9 were seen at day 6, compared to
day 14, independently of serum or Ca2+ concentration. In
the presence of serum, unstimulated cells produced higher
levels of mediators than without serum, and, except for IL8,
the increase of VEGF or MMP-9 triggered by IL-1β was
not signiﬁcant.
To extend these observations, diﬀerent chemokines and
cytokines were studied by magnetic bead suspension array
using the Bio-Plex Pro technology. The experiments were
conducted in serum-free medium to reduce the interferences
described in the previous paragraph. As shown in
Figures 4(a) and 4(b), the stimulation of HaCaT cells with
TNFα (10 ng/ml) for 48 h resulted in the upregulation of
secretion of almost all the 18 mediators tested in the diﬀerent
culture conditions, although the level of stimulation varied
among them. In particular, 6 days of culture in high Ca2+
concentration seem to represent the best combination for
optimal production of the majority of mediators, except for
CCL4/MIP1b, INFα2, INFγ, and G-CSF. Of note, CCL7/
MCP3 seemed to be the only cytokine strongly upregulated
by TNFα independently of the day of culture and Ca2+ con-
centration, whereas CCL22/MDC was the only cytokine for
which overconﬂuency, and not Ca2+ levels, contributed to
its production. On the contrary, Ca2+ concentration, but
not the days in culture, seemed to be particularly relevant
for TNFα-induced release of GM-CSF. No measurable values
for CXCL12/SDF-1, CX3CL1/fractalkine, or IL-33 were
obtained from any samples (data not shown).
3.3. Release of Inﬂammatory Mediators from Primary Human
Keratinocytes.The release of inﬂammatorymediatorswas also
measured in primary nonlesional epidermal KCs obtained
from psoriatic patients. These cells were grown in low Ca2+
medium and, when tested at 60–70% conﬂuence, showed
K10 expression comparable to A6 HaCaT cells (Figure 2(c)).
Regarding the production of cytokines/chemokines, normal
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KCs secreted basal level of all the molecules analyzed and the
treatment with TNFα induced a further increase of almost all
of them(Figures5(a)and5(b)).All theCXC chemokine family
members appeared to be highly upregulated, reaching a
value for the CXCL8/IL8 more than 20,000 pg/106 cells
(Figure 5(a)). Among the CC chemokines, only CCL2
showed approximately ﬁvefold increase above controls.
Of note, high concentration of growth factors, as TGFα
and GM-CSF, was detected in medium of primary KCs
stimulated with TNFα (Figure 5(b)).
4. Discussion
Keratinocytes are active players in epidermal repair and in
the skin’s immune defense through the secretion of growth
factors, cytokines, and chemokines. To facilitate and
standardize the in vitro studies on KCs, we investigated the
use of HaCaT cells as a suitable model to follow the release
of cutaneous inﬂammatory and repair mediators in response
to TNFα or IL-1β, and in relation to diﬀerent culture condi-
tions and diﬀerentiation levels.
HaCaT cells are a long-lived, spontaneously immortal-
ized human KC line, which exhibit basal cell properties and
display substantial changes in response to two well-
established in vitro prodiﬀerentiating agents: the increase in
cell density, as a function of time in culture, and extracellular
Ca2+ concentration.
The switch from low to high extracellular Ca2+ concen-
tration is considered not only a major regulator of the KC
diﬀerentiation, but also of their proliferation both in vitro
and in vivo. A Ca2+ gradient within the epidermis promotes
the sequential diﬀerentiation of KC from the basal layer to
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Figure 3: In vitro release of CXCL8/IL8, VEGF, andMMP-9 fromHaCaT cells stimulated by TNFα during cell diﬀerentiation. The amount of
CXCL8/IL8, VEGF, and MMP-9 was measured by ELISA in the supernatants of HaCaT cells plated at the same density (1.0× 104 cells/cm2),
grown in low (a) and high (C) Ca2+-containing medium for 6 (A6 and C6) or 14 (A14 and C14) days (white bars), and treated with 10 ng/ml
TNFα for 6 or 24 hours (black bars), as indicated, in the absence (a) or the presence (b) of serum. The data are expressed as pg/106 cells, and
values are the mean± SD of at least three independent experiments in duplicate.
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Figure 4: Bioplex multiplex system analysis of supernatants fromHaCaT cells stimulated by TNFα during cell diﬀerentiation. The amount of
chemokines (a), cytokines, and growth factors (b) was measured by Multiplex system technology in the supernatants of HaCaT cells plated at
1.0× 104 cells/cm2, grown in low (a) and high (c) Ca2+-containing medium for 6 (A6 and C6) and 14 (A14 and C14) days (white bars), and
treated with 10 ng/ml TNFα for 48 hours (black bars) in a serum-free medium. The data are expressed as pg/106 cells.
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the stratum corneum. Moreover, Ca2+ regulates the forma-
tion of desmosomes, adherent junctions, and tight junctions.
The latter maintain cell-cell adhesion and play an important
role in intracellular signaling that regulate Ca2+ levels and cell
cycle arrest, critical for the diﬀerentiation process [12].
With this in mind, we ﬁrst tested the diﬀerentiation
potential of HaCaT cells in response to the increase in cell
density and in extracellular Ca2+ concentration, by evalu-
ating the expression of three markers of diﬀerentiation,
namely K14, whose expression is restricted to the basal layer,
K10, and involucrin that indicate a more diﬀerentiated phe-
notype. Our data (Figure 1 and Table 1S) conﬁrm and extend
previous observations that the increase in cell density and
extracellular Ca2+ concentration favors HaCaT diﬀerentia-
tion [14–17]. HaCaT cells remain in the basal state (high
levels of K14) when maintained in low Ca2+ conditions and
less than 80% conﬂuent (A6), while they begin to diﬀerenti-
ate expressing high levels of K10 and involucrin after a
long-term culture (A14), that is when, although maintained
in low Ca2+ medium, they are overconﬂuent. Diﬀerent from
previous observations, we noticed that HaCaT cells maintain
their basal phenotype also when the cells are cultured in high
Ca2+ conditions, but at less than 80% conﬂuence. This obser-
vation suggests that, although extracellular Ca2+> 0.1mM
appears to be a major regulator of HaCaT diﬀerentiation,
the role of cell density is also relevant and it might have been
underestimated in previous in vitro studies.
Moreover, in our study, the Western blot analysis of K10
and involucrin expression showed that when HaCaT cells are
maintained in high Ca2+ condition, the overconﬂuence pro-
motes a slight decrease of both K10 and involucrin levels
and a weak increase of K14. Although this observation
may be a consequence of the lower density of C14 with
respect to A14, these data are in agreement with the
changes of Ca2+ and conﬂuence-dependent expression of
K1, a biomarker of more diﬀerentiated cells [20], but not with
the changes reported for the transglutaminase biomarker
[17]. Altogether, this emphasizes the importance of a careful
monitoring of diﬀerentiation marker expression during long-
term culture of HaCaT cells and of standardization of the
culture conditions.
The eﬀect of the Ca2+ switch on the proliferation of
HaCaT cells is poorly investigated. Our viability assays and
cell counts highlight that the extracellular Ca2+ concentration
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Figure 5: In vitro release of cytokines, chemokines, and growth factors from primary adult human keratinocytes stimulated by TNFα. The
amount of chemokines (a), of cytokines, and of growth factors (b) was measured by Multiplex system technology in the supernatants of
primary adult human keratinocytes (pKC) plated at the same density (8–10× 104 cells/cm2) and grown in low Ca2+-containing medium
(white bars). The treatment with 10 ng/ml TNFα was carried out for 48 hours in a serum-free medium when cells were 60–70% conﬂuent
(black bars). The data are expressed as pg/106 cells.
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strongly inﬂuences the proliferative ability of HaCaT cells.
Up to day 2 of culture, no diﬀerences in the proliferation rate
of HaCaT cells grown in low or high Ca2+ medium were seen,
whereas a diﬀerence in the growth rate was evident in low
Ca2+ medium starting from day 6, which became signiﬁ-
cantly higher at day 14. These ﬁndings are at variance of
those showing a progressive, time-dependent increase of
HaCaT proliferation in high Ca2+ medium [14]. A possible
explanation could be the higher extracellular Ca2+ concentra-
tion used in the present study (1.8mM) compared to 1.2mM
in [14]. In fact, it has been demonstrated that only an
increase in intracellular Ca2+ concentration above 1.5mM
results in a reduced growth rate [21].
In the second part of this study, HaCaT cells, cultured in
low or high Ca2+ medium for diﬀerent lengths of time, were
used to investigate the release of CXCL8/IL8, VEGF, and
MMP-9 in response to two proinﬂammatory stimuli, TNFα,
and IL-1β. These cytokines were chosen for their predomi-
nant role in the pathogenesis of skin inﬂammation, since they
both regulate genes previously shown to be speciﬁcally over-
expressed in psoriasis [10, 22–24]. Our results show that the
release of CXCL8/IL8, VEGF, and MMP-9 was higher in
HaCaT cell basal state (A6-C6) compared to more diﬀerenti-
ated cells (A14-C14). Ca2+ concentrations slightly enhanced
the secretion of these mediators, especially when IL-1β was
used as proinﬂammatory stimulus; this eﬀect could be
partially explained by the activation of the Ca2+ responsive
promoter of activator protein (AP)-1 [25].
The presence of serum reduced the TNFα-induced
release of MMP-9 and enhanced the VEGF secretion, both
at basal and stimulated levels. As previously reported, growth
factors derived from fetal calf serum may inﬂuence a variety
of parameters involved in KC proliferation, diﬀerentiation,
and wound healing processes [26–28]. Based on these results,
we strongly suggest that serum should not be used when the
proinﬂammatory mediators, VEGF, or MMP-9, are assayed.
This should be extended also to the assays using normal
human KC.
Several papers demonstrated that TNFα in KC regu-
lates diﬀerent genes involved in inﬂammation and angio-
genesis, such as IL-1, ICAM-1, VEGF [29, 30], TGF-β,
chemokines (CCL20, CCL27, CCL5, CCL2, CXCL10, and
CXCL11), and members of the CXCL8 family, including
CXCL1, CXCL2, and CXCL3 [10, 22, 23]. Therefore, using
the Multiplex technology, we evaluated the eﬀect of Ca2+
concentration and cellular density on the secretion of
diﬀerent cytokines, chemokines, and growth factors in
HaCaT cell line. All the analyzed parameters were upregu-
lated to a great extent by TNFα at day 6 in comparison to
day 14; only CCL22/MDC seemed to be preferentially
released in more diﬀerentiated HaCaT cells. CCL4, INFα2,
INFγ, and G-CSF had a higher release in low Ca2+ condi-
tion, whereas, on the opposite, in high Ca2+ concentration,
a comparable or higher secretion of CCL2, CCL3, CCL5,
CCL7, CCL11, CCL22, CXCL1, CXCL10, TGFα, TNF-β,
IL-10, and IL-15 was seen. To summarize, both long-
term culture and Ca2+ concentration in the medium aﬀect
the ability of HaCaT cells to release chemokines and
growth factors.
Finally, to validate HaCaT cells as a reliable model to dis-
sect the inﬂammatory/repair response of human KCs, we
measured the release of inﬂammatory mediators in primary
nonlesional epidermal KCs obtained from psoriatic patients.
These cells were assayed in low Ca2+medium and in the
absence of serum.
The levels of the CXC family of chemokines, induced by
TNFα on human KCs (CXCL1, CXCL8, and CXCL10) corre-
lated relatively well to the values released by HaCaT cells in
low Ca2+, considering the fold induction. Similar results were
obtained on growth factors released (TGFα, G-CSF, GM-
CSF, and VEGF). Not so close was the correlation with the
CC family of chemokines some of which (CCL4, CCL5,
CCL7, and CCL11) were highly released in A6 and C6
HaCaT cells, but quite low in normal human KCs; CCL2
was higher in C6 HaCaT as in normal KCs, whereas CCL3
was similar. Our results also show that HaCaT cells espe-
cially at day 14 of culture produce more CCL22/MDC
than normal human KCs, thus conﬁrming previously pub-
lished data [31, 32]. This is not the ﬁrst time that a diﬀerential
release of chemokines is described in primary human KCs or
HaCaT cells stimulated with exogenous stimuli. Data in the
literature reported that CXCL10 and IL8 were released to a
similar extent by both cell types, while CXCL9 and CCL20
were more eﬃciently produced by primary human KCs [33].
In conclusion, this study is the ﬁrst report where several
variables, all together, including the inﬂuence of Ca2+ con-
centration, the cell density, the diﬀerentiation state, and the
presence of serum, were considered as factors that may inﬂu-
ence release of proinﬂammatory mediators by KCs. Our
results support the use of HaCaT cell line, under carefully
optimized in vitro condition, as a reliable model, with respect
to normal KCs, to screen for new anti-inﬂammatory com-
pounds for skin diseases. Indeed, HaCaT cell line has been
successfully used for studying those pathologies in which
skin keratinocytes are involved, such as infectious diseases
or tumors, or as in vitro carcinogenesis model of human skin
[34]. By modulating Ca2+ concentration in culture medium
and maintaining 80% conﬂuence, HaCaT cells are in the con-
ditions of producing cytokines at medium/low levels (A6
condition) or at medium/high levels (C6 condition) as
expected in highly activated KCs from skin lesions. This
in vitro system has the advantage of being reproducible and
reliable and deﬁnitively less invasive and with less variability
than KC from skin biopsies. However, one of the drawbacks
is the inability of reproducing the skin complexity and
cellular heterogeneity in basal or inﬂammatory conditions.
2D-3D culture systems have been proposed which mimic
the diﬀerentiation process [35]. It cannot be excluded that
in a relatively short time we may have available 3D culture
systems in which several cell lineages KC, immune cells,
and ﬁbroblasts will be cocultured to ensure a better reproduc-
tion of the skin microenvironment.
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